Hickey Benjamin — SEC Form 4 filings

SEC reporting owner CIK 1753055. 16 Form 4 filings on record with FilingPulse; latest filed 2026-03-12.

Transaction summary — filings shown

Covers all 16 filings on record, filed 2024-01-09 to 2026-03-12. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
Mirati Therapeutics, Inc. (MRTX)EVP, Chief Commercial Officer33 legs · 3,687 sh · $217,3985
BRISTOL MYERS SQUIBB CO (BMY)President, RayzeBio Org.91 leg · 97 sh · $3,70219
Mural Oncology plc (MURA)Director46

Form 4 filings — Hickey Benjamin

FiledFormIssuerReported transactionsSource
2026-03-124BRISTOL MYERS SQUIBB CO (BMY)Grant/award (A): 11,429 (derivative) @ $0 · Grant/award (A): 17,143 (derivative) @ $0EDGAR
2026-03-034BRISTOL MYERS SQUIBB CO (BMY)Option exercise (M): 3,286 @ $0 · Tax withholding (F): 1,672 @ $62.37 · Option exercise (M): 3,286 (derivative) @ $0EDGAR
2026-02-034BRISTOL MYERS SQUIBB CO (BMY)Option exercise (M): 10,079 @ $0 · Tax withholding (F): 3,810 @ $55.05 · Option exercise (M): 10,079 (derivative) @ $0EDGAR
2025-12-054Mural Oncology plc (MURA)Disposition to issuer (D): 8,637 (derivative) · Disposition to issuer (D): 8,462 (derivative) · Disposition to issuer (D): 15,021 (derivative)EDGAR
2025-06-134Mural Oncology plc (MURA)Grant/award (A): 8,637 (derivative) @ $0EDGAR
2025-05-134BRISTOL MYERS SQUIBB CO (BMY)Sale (S): 97.39 @ $38.01EDGAR
2025-03-124BRISTOL MYERS SQUIBB CO (BMY)Grant/award (A): 13,389 (derivative) @ $0 · Grant/award (A): 20,084 (derivative) @ $0EDGAR
2025-03-044BRISTOL MYERS SQUIBB CO (BMY)Option exercise (M): 3,286 @ $0 · Tax withholding (F): 1,630 @ $59.62 · Option exercise (M): 3,286 (derivative) @ $0EDGAR
2025-02-044BRISTOL MYERS SQUIBB CO (BMY)Option exercise (M): 10,078 @ $0 · Tax withholding (F): 3,725 @ $58.95 · Option exercise (M): 10,078 (derivative) @ $0EDGAR
2024-06-054/AMural Oncology plc (MURA)Grant/award (A): 8,462 (derivative) @ $0EDGAR
2024-06-034Mural Oncology plc (MURA)Grant/award (A): 8,462 (derivative) @ $3.35EDGAR
2024-03-124BRISTOL MYERS SQUIBB CO (BMY)Grant/award (A): 3,870 (derivative) @ $0 · Grant/award (A): 5,805 (derivative) @ $0EDGAR
2024-03-044BRISTOL MYERS SQUIBB CO (BMY)Grant/award (A): 9,858 (derivative) @ $0EDGAR
2024-01-234Mirati Therapeutics, Inc. (MRTX)Disposition to issuer (D): 27,801 · Disposition to issuer (D): 72,206 · Disposition to issuer (D): 17,021 · Disposition to issuer (D): 2,128 (derivative) · Disposition to issuer (D): 43,328 (derivative)EDGAR
2024-01-184Mirati Therapeutics, Inc. (MRTX)Sale (S): 966 @ $59.02 · Sale (S): 631 @ $59.02EDGAR
2024-01-094Mirati Therapeutics, Inc. (MRTX)Sale (S): 2,090 @ $58.92EDGAR

FilingPulse's Form 4 archive currently extends back to 2024-01-09 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1753055 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →